GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biocartis Group NV (CHIX:BCARTb) » Definitions » 5-Year Yield-on-Cost %

Biocartis Group NV (CHIX:BCARTB) 5-Year Yield-on-Cost % : 0.00 (As of Jun. 22, 2025)


View and export this data going back to 2016. Start your Free Trial

What is Biocartis Group NV 5-Year Yield-on-Cost %?

Biocartis Group NV's yield on cost for the quarter that ended in Jun. 2023 was 0.00.


The historical rank and industry rank for Biocartis Group NV's 5-Year Yield-on-Cost % or its related term are showing as below:



CHIX:BCARTb's 5-Year Yield-on-Cost % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 1.98
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Biocartis Group NV's 5-Year Yield-on-Cost %

For the Diagnostics & Research subindustry, Biocartis Group NV's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biocartis Group NV's 5-Year Yield-on-Cost % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Biocartis Group NV's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Biocartis Group NV's 5-Year Yield-on-Cost % falls into.


;
;

Biocartis Group NV 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Biocartis Group NV is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Biocartis Group NV  (CHIX:BCARTb) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Biocartis Group NV 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Biocartis Group NV's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Biocartis Group NV Business Description

Traded in Other Exchanges
N/A
Address
Generaal de Wittelaan 11 B, Mechelen, BEL, 2800
Biocartis Group NV is a commercial-stage molecular diagnostics company. It provides diagnostic solutions aimed at improving clinical practice for patients, clinicians, payers, and the industry. The firm has developed an MDx Idylla molecular diagnostic system for oncology and infectious disease segments. Its products include EGFR mutation assay, BRAF mutation test, NRAS mutation test, respiratory panel, etc. The firm derives the majority of its revenues from product sales.

Biocartis Group NV Headlines

No Headlines